“…In 6 studies, the minimum follow-up period was not specified. Regarding the trigger site addressed, 10 studies focused exclusively on the frontal site, 11,12,16,27,34,43,50,52,59,64 5 on the temporal site, 28,41,49,60,65 9 on the occipital site, 13,15,39,42,47,51,53,54,63 4 on the nasal site, 14,33,37,48 and 20 on multiple sites. 10,18,20,[29][30][31][32]35,38,40,[44][45][46][56][57][58]61,62,66,67 In 4 studies, the addressed trigger site was not specified.…”